Corporate

MAC Clinical Research and Kariya Pharmaceuticals are pleased to share the successful dosing of the first cohort in the Phase

MAC Clinical Research (MAC) announces regulatory approval to initiate a PII clinical trial for mavatrep, an investigational, oral, TRPV1-receptor (transient

April is Stress Awareness Month and a perfect opportunity to reflect on the stress in our lives and how we

Taking a new treatment from lab to patient is a long, highly regulated process that demands years of research, significant

MAC Clinical Research is delighted to announce that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved amendments

Effective project management is vital to the success of a clinical trial, helping to ensure that studies are conducted smoothly,

At the end of 2024, MAC Laboratory Services reached an exciting milestone: full accreditation under the Good Laboratory Practice (GLP)

As we wrap up 2024, it’s the perfect time to look back at a year filled with exciting advancements, initiatives

MAC Clinical Research is proud to announce the successful completion of the single ascending dose (SAD) phase of the first-in-human

At MAC, patients and volunteers are more than participants – they are partners in everything we do. Their insights, experiences,